Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Faivre

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
International Journal of Oncology|July 13, 2005
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanismsAnne-Marie Coudray, Christophe Louvet, Michel Kornprobst, et al.
Head & Neck|February 9, 2005
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neckSandrine Faivre, Adina Marti, Olivier Rixe, et al.
World Journal of Hepatology|May 5, 2015
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapyChantal Dreyer, Marie-Paule Sablin, Mohamed Bouattour, et al.
Oncotarget|June 10, 2015
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patientsMaria Serova, Annemilaï Tijeras-Raballand, Célia Dos Santos, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2005
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinomaCatherine Delbaldo, Jean-Yves Pierga, Véronique Dieras, et al.
Targeted Oncology|January 14, 2025
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 StudyAntoine Desilets, Justin Lucas, Lisa F Licitra, et al.
Laryngoscope Investigative Otolaryngology|March 5, 2020
Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary resultsHannah Daoudi, Marc A Labeyrie, Sophie Guillerm, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2013
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosisGuilhem Bousquet, Mariana Varna, Irmine Ferreira, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signatureGabriel G Malouf, Sylvie Job, Valérie Paradis, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
International Journal of Oncology|July 13, 2005
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanismsAnne-Marie Coudray, Christophe Louvet, Michel Kornprobst, et al.
Head & Neck|February 9, 2005
Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neckSandrine Faivre, Adina Marti, Olivier Rixe, et al.
World Journal of Hepatology|May 5, 2015
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapyChantal Dreyer, Marie-Paule Sablin, Mohamed Bouattour, et al.
Oncotarget|June 10, 2015
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patientsMaria Serova, Annemilaï Tijeras-Raballand, Célia Dos Santos, et al.
European Journal of Cancer (Oxford, England : 1990)|July 30, 2005
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinomaCatherine Delbaldo, Jean-Yves Pierga, Véronique Dieras, et al.
Targeted Oncology|January 14, 2025
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 StudyAntoine Desilets, Justin Lucas, Lisa F Licitra, et al.
Laryngoscope Investigative Otolaryngology|March 5, 2020
Multimodal strategy for the management of sphenoid osteoradionecrosis: Preliminary resultsHannah Daoudi, Marc A Labeyrie, Sophie Guillerm, et al.
Molecular Cancer Therapeutics|April 17, 2008
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cellsMaria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Cancer Chemotherapy and Pharmacology|September 25, 2013
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosisGuilhem Bousquet, Mariana Varna, Irmine Ferreira, et al.
Hepatology (Baltimore, Md.)|January 21, 2014
Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signatureGabriel G Malouf, Sylvie Job, Valérie Paradis, et al.
Pageof 14